154 related articles for article (PubMed ID: 10910022)
1. Therapeutic apheresis application using membrane plasma fractionation technology: present scope and limitations.
Sueoka A
Ther Apher; 2000 Jun; 4(3):211-2. PubMed ID: 10910022
[TBL] [Abstract][Full Text] [Related]
2. Effect of membrane trapping in plasma fractionator on separative characteristics.
Mineshima M; Agishi T; Hasuo Y; Kaneko I; Era K; Ota K
Int J Artif Organs; 1988 May; 11(3):191-4. PubMed ID: 3403057
[TBL] [Abstract][Full Text] [Related]
3. A new module arrangement for plasmapheresis.
Hilke R; Albrecht W; Weidemann S; Groth T; Weigel T; Plagge A; Paul D
Transfus Apher Sci; 2001 Aug; 25(1):5-15. PubMed ID: 11791762
[TBL] [Abstract][Full Text] [Related]
4. Membranes for therapeutic apheresis.
Nakaji S; Yamamoto T
Ther Apher; 2002 Aug; 6(4):267-70. PubMed ID: 12164795
[TBL] [Abstract][Full Text] [Related]
5. Present status of apheresis technologies: Part 2. Membrane plasma fractionator.
Sueoka A
Ther Apher; 1997 May; 1(2):135-46. PubMed ID: 10225759
[TBL] [Abstract][Full Text] [Related]
6. Double filtration plasmapheresis: Review of current clinical applications.
Hirano R; Namazuda K; Hirata N
Ther Apher Dial; 2021 Apr; 25(2):145-151. PubMed ID: 32558286
[TBL] [Abstract][Full Text] [Related]
7. Membrane pore size and filtration selectivity in cryoglobulinemic plasma fractionation.
Zborowski M; Malchesky PS; Duggan PA; Koo AP
ASAIO Trans; 1991; 37(3):M490-1. PubMed ID: 1751247
[TBL] [Abstract][Full Text] [Related]
8. Asparaginase-associated concurrence of hyperlipidemia, hyperglobulinemia, and thrombocytosis was successfully treated by centrifuge/membrane hybrid double-filtration plasmapheresis.
Wang T; Xu B; Fan R; Liu Z; Gong D
J Clin Lipidol; 2016; 10(3):646-9. PubMed ID: 27206953
[TBL] [Abstract][Full Text] [Related]
9. Prediction of immunoglobulin M reduction via therapeutic dose of simple plasma exchange and double filtration plasmapheresis using membrane separation in patients with hyperviscosity syndrome caused by Waldenstrom macroglobulinemia.
Miyamoto Y; Hamasaki Y; Matsumoto A; Doi K; Noiri E; Nangaku M
J Clin Apher; 2018 Oct; 33(5):611-615. PubMed ID: 30188580
[TBL] [Abstract][Full Text] [Related]
10. [The sieving performance of a new polyethersulfone hollow fiber plasma fractionation membrane].
Zhao C; Liu T; Lu Z; Cheng L; Yu X; Yue Y
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2001 Mar; 18(1):5-8. PubMed ID: 11332114
[TBL] [Abstract][Full Text] [Related]
11. Plasma separator Plasmaflo OP.
Hirata N; Shizume Y; Shirokaze J; Suemitsu J; Yoshida H; Yamawaki N
Ther Apher Dial; 2003 Feb; 7(1):64-8. PubMed ID: 12921117
[TBL] [Abstract][Full Text] [Related]
12. An effective LDL removal filter for the treatment of hyperlipidemia.
Matsuda Y; Sueoka A; Nosé Y
Artif Organs; 1995 Feb; 19(2):129-34. PubMed ID: 7763191
[TBL] [Abstract][Full Text] [Related]
13. Performance evaluation of plasma fractionation membrane.
Zhao C; Zhang X; Yue YL
Ther Apher; 2002 Feb; 6(1):86-8. PubMed ID: 11886582
[TBL] [Abstract][Full Text] [Related]
14. Membrane plasmapheresis and the developing technology of plasma therapy.
Smith JW; Malchesky PS; Nosé Y
Cleve Clin Q; 1984; 51(1):135-42. PubMed ID: 6370505
[No Abstract] [Full Text] [Related]
15. Apheresis without substitution fluid: devices, directions and limitations.
Gurland HJ; Lysaght MJ; Samtleben W; Schmidt B; Stoffner D
Life Support Syst; 1984; 2(1):39-45. PubMed ID: 6471909
[TBL] [Abstract][Full Text] [Related]
16. Applications of membrane technologies for therapeutic apheresis.
Sueoka A
Ther Apher; 1998 Nov; 2(4):252-6. PubMed ID: 10227750
[TBL] [Abstract][Full Text] [Related]
17. The structure and characteristics of polypropylene hollow fiber membrane plasma separator.
Sakai M; Matsunami S
Ther Apher Dial; 2003 Feb; 7(1):69-72. PubMed ID: 12921118
[TBL] [Abstract][Full Text] [Related]
18. Unipuncture membrane plasmapheresis.
Verbanck JJ; Vanholder R; Schelstraete J; de Clippele M; Wulfrank DA; Deschryver AE; Ringoir SM
Artif Organs; 1983 Aug; 7(3):365-8. PubMed ID: 6625967
[TBL] [Abstract][Full Text] [Related]
19. Treatment of plasmapheresis refractory thrombotic thrombocytopenic purpura with double-filtration membrane plasmapheresis.
Karakus V; Deveci B; Kurtoğlu E
Transfus Apher Sci; 2013 Jun; 48(3):313-4. PubMed ID: 23631953
[TBL] [Abstract][Full Text] [Related]
20. Membrane plasmapheresis in the United States: a review over the last 20 years.
Siami GA; Siami FS
Ther Apher; 2001 Aug; 5(4):315-20. PubMed ID: 11724518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
